Clinical Trial Update: Study Evaluating The Effects Of Oprelvekin On Cardiac Repolarization In Subjects With Chemotherapy Induced Thrombocytopenia [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the effects of oprelvekin on cardiac repolarization in subjects with chemotherapy-induced thrombocytopenia was terminated, with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Thrombocytopenia

Drugs mentioned

• Neumega (interleukin-11)

Snippet

Sponsor: Pfizer | Conditions: Severe Thrombocytopenia | Phase 2 | Status: TERMINATED | Results posted: 2017-04-19